VEPESID, also known by its generic name etoposide, is a type of chemotherapy medication used in the treatment of various cancers, including lung cancer, testicular cancer, lymphoma, leukemia, and ovarian cancer. It belongs to a class of drugs known as podophyllotoxin derivatives, which work by inhibiting the enzyme topoisomerase II, leading to DNA damage and cell death in rapidly dividing cancer cells. VEPESID can be administered either orally in capsule form or intravenously, depending on the specific needs and condition of the patient. Like all chemotherapy drugs, VEPESID can cause side effects, which may include nausea, hair loss, low blood counts, and increased risk of infection, among others. Its use and dosage must be carefully monitored by a healthcare professional to balance the effectiveness in treating cancer with the potential for adverse effects.